Study guide
18.4 Blood Chemistry: Heme Metabolism, Hemoglobin & Plasma Proteins
APMLE Part I Basic Sciences Podiatry
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Lower Extremity Osteology
1.1 APMLE Part I Exam Structure, Policies & Scoring 1.2 Foot Osteology: Tarsals, Metatarsals, Phalanges & Sesamoids 1.3 Leg & Ankle Osteology: Tibia, Fibula & The Ankle Mortise 1.4 Pelvis, Femur & Patella Osteology: Landmarks & Biomechanics
2 Chapter 2: Lower Extremity Arthrology & Ligaments
2.1 Foot Articulations: Subtalar, Midtarsal, Lisfranc & Digital Joints 2.2 Talocrural (Ankle) & Knee Joints: Ligaments & Kinematics 2.3 Hip Joint & Pelvic Articulations: Capsular Structures & Dynamics
3 Chapter 3: Lower Extremity Myology & Compartments
3.1 Anterior & Lateral Compartments of the Leg 3.2 Superficial & Deep Posterior Compartments of the Leg 3.3 Plantar Layers & Intrinsic Musculature of the Foot 3.4 Thigh & Gluteal Musculature: Attachments & Innervations
4 Chapter 4: Lower Extremity Neurovascular & Topographical Anatomy
4.1 Lumbar & Sacral Plexuses, Peripheral Nerves & Dermatomes 4.2 Arterial Network, Venous Drainage & Lymphatics 4.3 Tarsal Tunnel, Femoral Triangle & Topographical Spaces
5 Chapter 5: Microbiology: Bacteriology, Zoonoses & Laboratory Methods
5.1 Gram-Positive Cocci & Bacilli in Podiatric Infections 5.2 Gram-Negative Bacilli & Opportunistic Pathogens 5.3 Anaerobic Pathogens & Diabetic Foot Infections 5.4 Bacterial Structure, Virulence Factors & Sterilization 5.5 Mycobacteria, Spirochetes, Mycoplasma & Zoonotic Infections 5.6 Antimicrobial Resistance, Susceptibility Testing, Specimen Handling & Vaccines
6 Chapter 6: Mycology, Virology, Parasitology & Clinical Immunology
6.1 Mycology: Dermatophytes, Onychomycosis & Systemic Mycoses 6.2 Clinically Relevant Viruses & Parasitic Infections 6.3 Innate & Adaptive Immunity Mechanisms 6.4 Hypersensitivity Reactions, Immunodeficiencies & Autoimmunity 6.5 Transplant & Tumor Immunology and Immunodiagnostic Methods
7 Chapter 7: General & Cellular Pathology
7.1 Cellular Injury, Adaptations & Cell Death Mechanisms 7.2 Acute vs Chronic Inflammation & Tissue Repair 7.3 Hemodynamic Disorders, Thrombosis, Embolism & Shock 7.4 Neoplasia, Oncogenes, Tumor Suppressors & Cutaneous Tumors
8 Chapter 8: Systemic & Podiatric Pathology
8.1 Atherosclerosis, Peripheral Artery Disease & Diabetic Microangiopathy 8.2 Osteoarthritis, Inflammatory Arthritides & Bone Infections 8.3 Neuropathic Disorders, Charcot Neuroarthropathy & Dermatopathology 8.4 Laboratory Diagnostics, Synovial Fluid & Biopsy Interpretation
9 Chapter 9: Organ-System Pathology
9.1 Anemias, Hemoglobinopathies, Leukemias & Immune Disorders 9.2 Cardiac & Pulmonary Pathology 9.3 Renal, Urogenital & Reproductive Pathology 9.4 Gastrointestinal, Hepatobiliary & Endocrine Pathology
10 Chapter 10: General Pharmacology, Autonomic Drugs & Toxicology
10.1 Pharmacokinetics, ADME & Receptor Dynamics 10.2 Cholinergic Agonists & Muscarinic/Nicotinic Antagonists 10.3 Adrenergic Agonists, Sympatholytics & Clinical Applications 10.4 Cardiovascular Pharmacology in Podiatric Patients 10.5 Drug Interactions, Adverse Effects, Pharmacogenomics & Toxicology
11 Chapter 11: Antimicrobial & Podiatric Therapeutics
11.1 Antibacterial Classes, Mechanisms & Resistances 11.2 Antifungal, Antiviral & Antiparasitic Therapeutics 11.3 NSAIDs, Opioids, Corticosteroids & Anti-Gout Agents 11.4 Local & General Anesthetic Pharmacology
12 Chapter 12: Systemic Pharmacology
12.1 Anticonvulsants, Antidepressants, Psychotropics & Skeletal Muscle Relaxants 12.2 Insulin & Noninsulin Glycemic Agents 12.3 Respiratory & Gastrointestinal Agents 12.4 DMARDs, Biologics, Antineoplastics & Immunosuppressants 12.5 Hormone Therapy, Bisphosphonates, Antihistamines, Growth Factors & Complementary Agents
13 Chapter 13: General Anatomy: Systemic Gross Anatomy & Neuroanatomy
13.1 Cranial Nerves, Head & Neck Anatomy 13.2 Thoracic Wall, Tracheobronchial Tree, Lungs & Mediastinum 13.3 Abdominal Wall, GI Viscera, Pelvis & Retroperitoneum 13.4 Vertebral Column, Spinal Cord & Upper Extremity Overview 13.5 Neuroanatomy: CNS Organization, Somatosensory & Motor Pathways
14 Chapter 14: Histology, Integument, Embryology & Genetics
14.1 Microscopic Anatomy: Epithelia, Connective Tissue, Muscle & Nerve 14.2 Integumentary System: Dermis, Appendages, Nail Unit & Cutaneous Receptors 14.3 Embryogenesis, Limb Morphogenesis & Postnatal Development 14.4 Medical Genetics & Structural Alterations in Aging
15 Chapter 15: Cellular, Neuromuscular & Cardiovascular Physiology
15.1 Membrane Potential, Ion Channels & Transport Mechanisms 15.2 Action Potentials, Synaptic Transmission & Muscle Contraction 15.3 Cardiac Electrophysiology, ECG & Hemodynamics 15.4 Blood Pressure Regulation, Poiseuille Law & Capillary Dynamics
16 Chapter 16: Organ-System Physiology: Respiratory, Renal, Endocrine, GI & Blood
16.1 Pulmonary Mechanics, Gas Exchange & Acid-Base Regulation 16.2 Renal Filtration, Tubular Transport & Fluid/Acid-Base Balance 16.3 Endocrine Regulation, Reproductive Hormones, Calcium & Bone 16.4 Gastrointestinal & Hepatobiliary Physiology 16.5 Hematology: Erythropoiesis, Leukocytes, Platelets & Coagulation 16.6 Exercise Physiology, Thermoregulation & Bone Mechanobiology
17 Chapter 17: Biochemistry: Proteins, Enzymes, Carbohydrates & Signaling
17.1 Amino Acid Chemistry, Protein Structure & Enzyme Kinetics 17.2 Glycolysis, Gluconeogenesis, Glycogen Metabolism & TCA Cycle 17.3 Electron Transport Chain, ATP Synthesis & Metabolic Inborn Errors 17.4 Hormones, Receptors, Second Messengers & Signal Transduction
18 Chapter 18: Biochemistry: Lipids, Molecular Genetics, Blood Chemistry & Nutrition
18.1 Fatty Acid Oxidation, Ketogenesis, Cholesterol & Lipoproteins 18.2 Nucleotide Metabolism, DNA Replication, Transcription, Translation & Repair 18.3 Vitamins, Micronutrients & Inborn Errors of Metabolism 18.4 Blood Chemistry: Heme Metabolism, Hemoglobin & Plasma Proteins 18.5 Nutrition: Energy Balance, Glycemic Index, Fed-Fast Cycle & Free Radicals
18.4 Blood Chemistry: Heme Metabolism, Hemoglobin & Plasma Proteins
Key Takeaways Explain This Topic AI
Heme synthesis starts in mitochondria with ALA synthase (glycine plus succinyl-CoA, requiring vitamin B6), the rate-limiting step; lead inhibits ALA dehydratase and ferrochelatase.
Acute intermittent porphyria (porphobilinogen deaminase deficiency) causes abdominal pain, neuropathy and psychiatric symptoms triggered by certain drugs, alcohol and fasting; porphyria cutanea tarda (uroporphyrinogen decarboxylase) causes photosensitive blisters.
Heme is degraded to biliverdin, then bilirubin, which travels bound to albumin, is conjugated by UGT1A1 in the liver and excreted in bile; the color changes of a healing bruise reflect hemoglobin breakdown to biliverdin and bilirubin.
Fetal hemoglobin binds 2,3-BPG poorly and has higher oxygen affinity; HbS (beta-6 glutamate to valine) polymerizes when deoxygenated, and HbA1c reflects nonenzymatic glycation over roughly the prior 3 months.
Plasma osmolality can be estimated as 2 × Na + glucose/18 + BUN/2.8 (in mg/dL units), giving about 290 mOsm/kg with normal values; albumin is the main oncotic protein and a negative acute-phase reactant.
Last updated: October 2026
18.4 Blood Chemistry: Heme Metabolism, Hemoglobin & Plasma Proteins
The biochemistry outline lists blood chemistry : heme metabolism, hemostasis and blood coagulation, plasma composition, and molecular aspects of erythrocytes and hemoglobin. Oxygen-hemoglobin dissociation is covered in 16.1, red cell physiology and the coagulation cascade in 16.5, and hemoglobinopathies as diseases in 9.1. This section covers the molecular basis.
Heme Synthesis
Heme (protoporphyrin IX plus Fe2+) is made mostly in the bone marrow (for hemoglobin) and the liver (for cytochromes, including the CYP450 enzymes).
Step Enzyme Location Clinical note
Glycine + succinyl-CoA to delta-aminolevulinic acid (ALA) ALA synthase (rate-limiting; requires vitamin B6 ) Mitochondria Induced by many drugs and by low heme; inhibited by heme and glucose
ALA to porphobilinogen ALA dehydratase Cytosol Inhibited by lead
Porphobilinogen to hydroxymethylbilane Porphobilinogen deaminase Cytosol Deficient in acute intermittent porphyria
Uroporphyrinogen III to coproporphyrinogen III Uroporphyrinogen decarboxylase Cytosol Deficient in porphyria cutanea tarda
- Protoporphyrin IX + Fe2+ to heme Ferrochelatase Mitochondria Inhibited by lead
- Porphyrias and Lead Poisoning
Acute intermittent porphyria: autosomal dominant with variable penetrance. Attacks cause severe abdominal pain , a predominantly motor peripheral neuropathy , psychiatric symptoms, tachycardia and dark or red urine with high urinary porphobilinogen . Triggers include CYP-inducing drugs (barbiturates, some anticonvulsants, sulfonamides), alcohol, fasting and progesterone. Treatment is IV hemin and glucose, which suppress ALA synthase.
Porphyria cutanea tarda: the most common porphyria. It causes photosensitive blistering and fragility on the backs of the hands , hypertrichosis and scarring, and is associated with hepatitis C, alcohol, estrogens and hemochromatosis. It is treated with phlebotomy or low-dose hydroxychloroquine.
Lead poisoning: inhibits ALA dehydratase and ferrochelatase, causing microcytic anemia with basophilic stippling and ringed sideroblasts, abdominal colic, wrist or foot drop (motor neuropathy) and encephalopathy in children. Chelation uses succimer, edetate calcium disodium or dimercaprol.
Heme Degradation and Bilirubin
Macrophages (mainly in the spleen) open the heme ring with heme oxygenase , releasing Fe2+ (recycled), CO and biliverdin (green) .
Biliverdin reductase forms unconjugated bilirubin (yellow) , which is insoluble and carried to the liver on albumin .
Hepatocytes conjugate it with glucuronic acid using UGT1A1 , forming water-soluble conjugated bilirubin that is secreted into bile.
Gut bacteria convert it to urobilinogen . Some is reabsorbed and excreted in urine as urobilin, and the rest becomes stercobilin , which colors stool.
A bruise changes color as hemoglobin breaks down: red-blue or purple at first, then green (biliverdin) and yellow-brown (bilirubin, hemosiderin) over several days. This sequence is seen around ankle sprains and after foot surgery.
Hyperbilirubinemia Mechanism
Unconjugated (indirect) Hemolysis; Gilbert syndrome (reduced UGT1A1, mild jaundice with fasting or illness); Crigler-Najjar syndrome (absent or severely reduced UGT1A1); neonatal jaundice
Conjugated (direct) Biliary obstruction (stones, pancreatic cancer); hepatitis; Dubin-Johnson syndrome (black liver) and Rotor syndrome. Conjugated bilirubin appears in urine, making it dark
Hemoglobin: Structure and Molecular Aspects
- Hemoglobin Chains Notes
- HbA alpha-2, beta-2 About 95–98% of adult hemoglobin
- HbA2 alpha-2, delta-2 Increased in beta-thalassemia trait
HbF alpha-2, gamma-2 Binds 2,3-BPG poorly , so it has higher oxygen affinity , aiding transfer from the maternal circulation; hydroxyurea raises HbF in sickle cell disease
Cooperativity: hemoglobin moves between a low-affinity taut (T) state and a high-affinity relaxed (R) state, producing the sigmoid dissociation curve.
Bohr effect: H+ and CO2 stabilize the T state and release oxygen in active tissues.
2,3-BPG , made in red cells by the Rapoport-Luebering shunt off glycolysis, binds the central cavity of deoxyhemoglobin and shifts the curve right. It rises with chronic anemia and high altitude.
CO2 transport: about 70% as bicarbonate (carbonic anhydrase in red cells with the chloride shift), about 20–25% as carbaminohemoglobin , and about 5–10% dissolved. The Haldane effect describes how deoxygenated hemoglobin carries more CO2.
Methemoglobin (Fe3+) cannot carry oxygen. It is reduced by NADH-cytochrome b5 reductase , and in emergencies by methylene blue through NADPH (11.4).
Molecular hemoglobinopathies:
HbS: beta-6 glutamate to valine . The hydrophobic valine allows deoxygenated HbS to polymerize .
HbC: beta-6 glutamate to lysine . It causes milder disease with target cells.
Alpha-thalassemia usually results from gene deletions (four alpha genes): one deletion is a silent carrier, two cause trait, three cause HbH disease and four cause hydrops fetalis with Hb Barts.
Beta-thalassemia results from point mutations , often affecting splicing or promoters (beta-zero or beta-plus alleles).
Glycated hemoglobin (HbA1c) forms by nonenzymatic attachment of glucose to the N-terminal valine of the beta chain. It reflects average glucose over the red cell lifespan, roughly the prior 3 months . Conditions that shorten red cell survival (hemolysis, blood loss, transfusion) or alter hemoglobin can make HbA1c misleading.
Erythrocyte Metabolism
Red cells lack mitochondria, so they rely on anaerobic glycolysis (net 2 ATP per glucose). Pyruvate kinase deficiency starves the Na+/K+-ATPase and causes hemolysis. The hexose monophosphate shunt supplies NADPH to keep glutathione reduced; G6PD deficiency therefore causes oxidant hemolysis with Heinz bodies (17.3).
Plasma Composition
Plasma is blood without cells; serum is plasma without clotting factors (fibrinogen is consumed in the clot).
Protein fraction (electrophoresis) Major members Function
Albumin (about 3.5–5.0 g/dL) About 75–80% of plasma oncotic pressure ; carries bilirubin, fatty acids, calcium and acidic drugs (warfarin, phenytoin)
Alpha-1 globulins Alpha-1 antitrypsin, alpha-1 acid glycoprotein Protease inhibition; binds basic drugs such as lidocaine
Alpha-2 globulins Haptoglobin, ceruloplasmin, alpha-2 macroglobulin Haptoglobin binds free hemoglobin (low in hemolysis)
- Beta globulins Transferrin, LDL, C3 Iron transport, lipids, complement
- Gamma globulins Immunoglobulins A monoclonal M-spike suggests multiple myeloma (9.1)
- Fibrinogen Coagulation; raises the ESR
Acute-phase reactants are driven by IL-6:
- Positive (rise): CRP, fibrinogen, ferritin, hepcidin, serum amyloid A, haptoglobin
- Negative (fall): albumin, transferrin, transthyretin (prealbumin)
Low albumin in an infected or inflamed patient therefore reflects inflammation as well as nutrition (18.5).
Plasma osmolality can be estimated from routine chemistry (sodium in mEq/L; glucose and BUN in mg/dL): Osm calc = 2 [ Na + ] + glucose 18 + BUN 2.8 \text{Osm}_{\text{calc}} = 2[\text{Na}^+] + \frac{\text{glucose}}{18} + \frac{\text{BUN}}{2.8} Osm calc = 2 [ Na + ] + 18 glucose + 2.8 BUN
With Na+ 140, glucose 90 and BUN 14: 280 + 5 + 5 = 290 mOsm/kg . A measured value well above the calculated value (an osmolal gap ) suggests unmeasured osmoles such as ethanol, methanol or ethylene glycol.
Biochemistry of Hemostasis
Vitamin K-dependent gamma-carboxylation: vitamin K hydroquinone serves as cofactor for gamma-glutamyl carboxylase, adding a second carboxyl group to glutamate residues on factors II, VII, IX and X and proteins C and S . The resulting Gla residues bind Ca2+, anchoring the factors to phospholipid membranes. Vitamin K epoxide reductase (VKORC1) regenerates the cofactor and is the target of warfarin.
Factor XIIIa is a transglutaminase that forms covalent links between glutamine and lysine residues of adjacent fibrin monomers, stabilizing the clot.
von Willebrand factor is a large multimer that bridges platelets to collagen and carries factor VIII in plasma, protecting it from degradation.
Antithrombin is a serine protease inhibitor (serpin) activated by heparin's pentasaccharide sequence.